Copyright Reports & Markets. All rights reserved.

Global Sodium Iodine (131I) Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Sodium Iodine (131I) Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Sodium Iodine 131I Capsules
    • 1.3.3 Sodium iodine 131I Oral Solution
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Sodium Iodine (131I) Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Diagnosis and Investigation
    • 1.4.3 Hyperthyroidism
    • 1.4.4 Thyroid Cancer
  • 1.5 Global Sodium Iodine (131I) Drugs Market Size & Forecast
    • 1.5.1 Global Sodium Iodine (131I) Drugs Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Sodium Iodine (131I) Drugs Sales Quantity (2021-2032)
    • 1.5.3 Global Sodium Iodine (131I) Drugs Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Jubilant Radiopharma
    • 2.1.1 Jubilant Radiopharma Details
    • 2.1.2 Jubilant Radiopharma Major Business
    • 2.1.3 Jubilant Radiopharma Sodium Iodine (131I) Drugs Product and Services
    • 2.1.4 Jubilant Radiopharma Sodium Iodine (131I) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Jubilant Radiopharma Recent Developments/Updates
  • 2.2 AnazaoHealth
    • 2.2.1 AnazaoHealth Details
    • 2.2.2 AnazaoHealth Major Business
    • 2.2.3 AnazaoHealth Sodium Iodine (131I) Drugs Product and Services
    • 2.2.4 AnazaoHealth Sodium Iodine (131I) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 AnazaoHealth Recent Developments/Updates
  • 2.3 International Isotopes
    • 2.3.1 International Isotopes Details
    • 2.3.2 International Isotopes Major Business
    • 2.3.3 International Isotopes Sodium Iodine (131I) Drugs Product and Services
    • 2.3.4 International Isotopes Sodium Iodine (131I) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 International Isotopes Recent Developments/Updates
  • 2.4 Bracco
    • 2.4.1 Bracco Details
    • 2.4.2 Bracco Major Business
    • 2.4.3 Bracco Sodium Iodine (131I) Drugs Product and Services
    • 2.4.4 Bracco Sodium Iodine (131I) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Bracco Recent Developments/Updates
  • 2.5 Mallinckrodt
    • 2.5.1 Mallinckrodt Details
    • 2.5.2 Mallinckrodt Major Business
    • 2.5.3 Mallinckrodt Sodium Iodine (131I) Drugs Product and Services
    • 2.5.4 Mallinckrodt Sodium Iodine (131I) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Mallinckrodt Recent Developments/Updates
  • 2.6 Hta Co., Ltd
    • 2.6.1 Hta Co., Ltd Details
    • 2.6.2 Hta Co., Ltd Major Business
    • 2.6.3 Hta Co., Ltd Sodium Iodine (131I) Drugs Product and Services
    • 2.6.4 Hta Co., Ltd Sodium Iodine (131I) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Hta Co., Ltd Recent Developments/Updates
  • 2.7 Yantai Dongcheng Biochemicals Co.,Ltd.
    • 2.7.1 Yantai Dongcheng Biochemicals Co.,Ltd. Details
    • 2.7.2 Yantai Dongcheng Biochemicals Co.,Ltd. Major Business
    • 2.7.3 Yantai Dongcheng Biochemicals Co.,Ltd. Sodium Iodine (131I) Drugs Product and Services
    • 2.7.4 Yantai Dongcheng Biochemicals Co.,Ltd. Sodium Iodine (131I) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Yantai Dongcheng Biochemicals Co.,Ltd. Recent Developments/Updates
  • 2.8 Chengdu Gaotong Isotope Co.,Ltd.
    • 2.8.1 Chengdu Gaotong Isotope Co.,Ltd. Details
    • 2.8.2 Chengdu Gaotong Isotope Co.,Ltd. Major Business
    • 2.8.3 Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodine (131I) Drugs Product and Services
    • 2.8.4 Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodine (131I) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Chengdu Gaotong Isotope Co.,Ltd. Recent Developments/Updates
  • 2.9 BWXT Medical Ltd
    • 2.9.1 BWXT Medical Ltd Details
    • 2.9.2 BWXT Medical Ltd Major Business
    • 2.9.3 BWXT Medical Ltd Sodium Iodine (131I) Drugs Product and Services
    • 2.9.4 BWXT Medical Ltd Sodium Iodine (131I) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 BWXT Medical Ltd Recent Developments/Updates

3 Competitive Environment: Sodium Iodine (131I) Drugs by Manufacturer

  • 3.1 Global Sodium Iodine (131I) Drugs Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Sodium Iodine (131I) Drugs Revenue by Manufacturer (2021-2026)
  • 3.3 Global Sodium Iodine (131I) Drugs Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Sodium Iodine (131I) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Sodium Iodine (131I) Drugs Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Sodium Iodine (131I) Drugs Manufacturer Market Share in 2025
  • 3.5 Sodium Iodine (131I) Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Sodium Iodine (131I) Drugs Market: Region Footprint
    • 3.5.2 Sodium Iodine (131I) Drugs Market: Company Product Type Footprint
    • 3.5.3 Sodium Iodine (131I) Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Sodium Iodine (131I) Drugs Market Size by Region
    • 4.1.1 Global Sodium Iodine (131I) Drugs Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Sodium Iodine (131I) Drugs Consumption Value by Region (2021-2032)
    • 4.1.3 Global Sodium Iodine (131I) Drugs Average Price by Region (2021-2032)
  • 4.2 North America Sodium Iodine (131I) Drugs Consumption Value (2021-2032)
  • 4.3 Europe Sodium Iodine (131I) Drugs Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Sodium Iodine (131I) Drugs Consumption Value (2021-2032)
  • 4.5 South America Sodium Iodine (131I) Drugs Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Sodium Iodine (131I) Drugs Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Sodium Iodine (131I) Drugs Sales Quantity by Type (2021-2032)
  • 5.2 Global Sodium Iodine (131I) Drugs Consumption Value by Type (2021-2032)
  • 5.3 Global Sodium Iodine (131I) Drugs Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Sodium Iodine (131I) Drugs Sales Quantity by Application (2021-2032)
  • 6.2 Global Sodium Iodine (131I) Drugs Consumption Value by Application (2021-2032)
  • 6.3 Global Sodium Iodine (131I) Drugs Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Sodium Iodine (131I) Drugs Sales Quantity by Type (2021-2032)
  • 7.2 North America Sodium Iodine (131I) Drugs Sales Quantity by Application (2021-2032)
  • 7.3 North America Sodium Iodine (131I) Drugs Market Size by Country
    • 7.3.1 North America Sodium Iodine (131I) Drugs Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Sodium Iodine (131I) Drugs Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Sodium Iodine (131I) Drugs Sales Quantity by Type (2021-2032)
  • 8.2 Europe Sodium Iodine (131I) Drugs Sales Quantity by Application (2021-2032)
  • 8.3 Europe Sodium Iodine (131I) Drugs Market Size by Country
    • 8.3.1 Europe Sodium Iodine (131I) Drugs Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Sodium Iodine (131I) Drugs Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Sodium Iodine (131I) Drugs Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Sodium Iodine (131I) Drugs Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Sodium Iodine (131I) Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Sodium Iodine (131I) Drugs Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Sodium Iodine (131I) Drugs Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Sodium Iodine (131I) Drugs Sales Quantity by Type (2021-2032)
  • 10.2 South America Sodium Iodine (131I) Drugs Sales Quantity by Application (2021-2032)
  • 10.3 South America Sodium Iodine (131I) Drugs Market Size by Country
    • 10.3.1 South America Sodium Iodine (131I) Drugs Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Sodium Iodine (131I) Drugs Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Sodium Iodine (131I) Drugs Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Sodium Iodine (131I) Drugs Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Sodium Iodine (131I) Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Sodium Iodine (131I) Drugs Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Sodium Iodine (131I) Drugs Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Sodium Iodine (131I) Drugs Market Drivers
  • 12.2 Sodium Iodine (131I) Drugs Market Restraints
  • 12.3 Sodium Iodine (131I) Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Sodium Iodine (131I) Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Sodium Iodine (131I) Drugs
  • 13.3 Sodium Iodine (131I) Drugs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Sodium Iodine (131I) Drugs Typical Distributors
  • 14.3 Sodium Iodine (131I) Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Sodium Iodine (131I) Drugs market size was valued at US$ 33.61 million in 2025 and is forecast to a readjusted size of US$ 51.79 million by 2032 with a CAGR of 6.4% during review period.
    Sodium iodide I 131 is used to treat hyperthyroidism (an overactive thyroid) and certain kinds of thyroid cancer. This medicine is taken up mainly by the thyroid gland.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Sodium Iodine (131I) Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Sodium Iodine (131I) Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Sodium Iodine (131I) Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Sodium Iodine (131I) Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Sodium Iodine (131I) Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Sodium Iodine (131I) Drugs
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Sodium Iodine (131I) Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jubilant Radiopharma, AnazaoHealth, International Isotopes, Bracco, Mallinckrodt, Hta Co., Ltd, Yantai Dongcheng Biochemicals Co.,Ltd., Chengdu Gaotong Isotope Co.,Ltd., BWXT Medical Ltd, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Sodium Iodine (131I) Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Sodium Iodine [131I] Capsules
    Sodium iodine [131I] Oral Solution
    Market segment by Application
    Diagnosis and Investigation
    Hyperthyroidism
    Thyroid Cancer
    Major players covered
    Jubilant Radiopharma
    AnazaoHealth
    International Isotopes
    Bracco
    Mallinckrodt
    Hta Co., Ltd
    Yantai Dongcheng Biochemicals Co.,Ltd.
    Chengdu Gaotong Isotope Co.,Ltd.
    BWXT Medical Ltd
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Sodium Iodine (131I) Drugs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Sodium Iodine (131I) Drugs, with price, sales quantity, revenue, and global market share of Sodium Iodine (131I) Drugs from 2021 to 2026.
    Chapter 3, the Sodium Iodine (131I) Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Sodium Iodine (131I) Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Sodium Iodine (131I) Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Sodium Iodine (131I) Drugs.
    Chapter 14 and 15, to describe Sodium Iodine (131I) Drugs sales channel, distributors, customers, research findings and conclusion.

    Buy now